title: Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review.
abstract: A growing body of evidence indicates that proviral DNA load quantitation is an important parameter in establishing the dynamics of HIV infection. Proviral DNA load can be determined during the follow-up of infected individuals to evaluate reservoir status in addition to viral replication. Hence, the study of viral reservoirs, represented by HIV-1 latently infected cells, including resting memory CD4+ T cells, monocytes and macrophages, by which HIV-1 can be reactivated, opens new perspectives in the assessment and the comprehension of HIV-1 infection. However, the identification of viral reservoirs, that can store both wild and drug resistance viruses, is one of the most important steps in developing treatment strategies because it is now clear that viral reservoirs not only prevent sterilizing immunity but also represent a major obstacle to curing the infection with the potent antiretroviral drugs currently in use. Even if only careful evaluation of virological and immunological markers is necessary to fully characterize the course of HIV-1 infection and to provide a more complete laboratory-based assessment of disease progression, the availability of a new standardized assay such as DNA proviral load will be important to assess the true extent of virological suppression in treated patients and to verify the efficacy of new immune-based therapies aimed at purging HIV-1 DNA reservoirs. Several studies demonstrate, in fact, that HIV-1 cellular DNA load may be an indicator of spread of infection whereas the plasma RNA load is indicates active infection. This article will review the importance of monitoring HIV-1 proviral load DNA during the follow-up of HIV-1 infected subjects, suggesting that additional information complementing HIV RNA load could provide crucial information to monitor viral replication and the effectiveness of HAART therapy.
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Microbiology, University of Bologna, St. Orsola Hospital, Massarenti, 9, 40138 Bologna, Italy. mariacarla.re@unibo.it
authors.forename: Maria Carla
authors.initials: MC
authors.lastname: Re
authors.forename: Francesca
authors.initials: F
authors.lastname: Vitone
authors.forename: Isabella
authors.initials: I
authors.lastname: Bon
authors.forename: Pasqua
authors.initials: P
authors.lastname: Schiavone
authors.forename: Davide
authors.initials: D
authors.lastname: Gibellini
mesh_terms: D004279:DNA, Viral / Q000235:genetics*; D005500:Follow-Up Studies; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000235:genetics* / Q000502:physiology; D006801:Humans; D012313:RNA / Q000235:genetics; D019562:Viral Load; D016662:Virus Integration / Q000235:genetics; D017735:Virus Latency; D014779:Virus Replication / Q000235:genetics
chemical_list: D004279:DNA, Viral; D012313:RNA